Aurobindo Pharma gains on highest-ever quarterly sales, profit boost
Aurobindo Pharma will pay its first interim dividend of the fiscal year 2024 at Rs 3 per share
Source: moneycontrol.com
Nithyananda Reddy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nithyananda Reddy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nithyananda Reddy Today - Breaking & Trending Today
BioFactura and CuraTeQ Sign Exclusive License for BFI-751—A Biosimilar to Stelara
Frederick, Maryland (PRWEB) July 10, 2023 -- BioFactura, Inc. today announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo
Source: prweb.com
aurobindo pharma share price: Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib Capsules
Shares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with Medicines Patent Pool to create and market a generic version of Nilotinib Capsules. Aurobindo Pharmas wholly-owned subsidiary Eugia Pharma Specialities has entered a voluntary sublicensing agreement with Medicines Patent Pool to manufacture and market the drug in 44 low and middle-income countries for the treatment of chronic myeloid leukemia.
Source: indiatimes.com
Aurobindo Pharma slumps 3% after weak Q4 numbers
Aurobindo Pharma reported a 12 percent YoY decline in net profit at Rs 506 crore. Investec, however, has a 'buy' call on the stock, with a target price of Rs 560 . The company has shown strong performance in the US market, it said
Source: moneycontrol.com
Generic manufacturers sign sublicences to produce HIV medicine
Sublicence agreements signed by the MPP and three generic manufacturers could enable millions to access a long-acting HIV medicine.
Source: europeanpharmaceuticalreview.com